Feature | April 27, 2012

Cardiovascular Nuclear Imaging Advances Highlighted at SNM Symposium

April 27, 2012 — More than 150 molecular imaging professionals gathered last week at the Society of Nuclear Medicine’s third Multimodality Cardiovascular Molecular Imaging Symposium held at the National Institutes of Health. The two and a half day symposium brought together individuals from multiple scientific disciplines — including chemistry, engineering, physics, molecular biology, cardiovascular physiology and imaging sciences — with the goal of promoting the emerging field of cardiovascular molecular imaging.

“Our program this year focused on advances in targeted imaging of the cardiovascular system including imaging of cardiovascular receptors, stem cell therapy, vascular biology, myocardial metabolism and other relevant biological processes,” said Albert J. Sinusas, M.D., program chair of the symposium. “The symposium proved to be very successful, stimulating further interest in the field and advancing the promotion of basic science research and the development of clinical applications in cardiovascular molecular imaging.”

The first day of the symposium highlighted the development and application of novel imaging probes for evaluation and treatment of cardiovascular disease, along with novel hybrid imaging technology. The imaging technologies reviewed included; fluorescence imaging, chemical exchange saturation contrast imaging, optoacoustic imaging, multispectral CT as well as microSPECT and microPET imaging. Professor Jason S. Lewis, Ph.D., vice chair of radiology and chief attending of the radiochemistry and imaging sciences service in the Department of Radiology at Memorial Hospital for Cancer and Allied Diseases, in New York City, presented a keynote address on molecular imaging agents that are currently in translation for imaging cancer.

Lewis noted, “Now is a particularly interesting time for the field of cardiology. We have multiple new agents coming down the pipeline in the oncology world that can be used in various imaging capacities; there are hopefully a lot of interesting parallels and lessons to be learnt in the nuclear cardiology field based on our experience with cancer. Having these new targeted imaging options allows us to personalize medicine to make sure that the patient is getting the most appropriate test for their indication.”

Attendees switched their focus to specific diseases on day two of the symposium and learned about imaging of atherosclerosis and vascular remodeling, imaging angiogenesis and arteriogenesis, metabolic imaging of the heart, imaging of myocardial injury, repair and remodeling. Ira Tabas, M.D., Ph.D., provided another keynote lecture on the pathophysiology of atherosclerosis, and the associated implications for targeted imaging of the vasculature. The symposium concluded with sessions on stem cell therapy and challenges of translation of molecular imaging and therapy, with a third keynote lecture by Lee Josephson, Ph.D.

In addition to scientific program, a total of 22 abstracts representing the most novel ideas in molecular imaging research as applied to the cardiovascular system, were accepted for the symposium’s poster session. The winning abstract for the symposium was “Quantitative first-pass perfusion MRI of the mouse heart: data acquisition, reconstruction, and analysis strategies,” authored by N.K. Naresh. The first runner-up was “Therapeutic efficacy of different liposomal glucocorticoids as a treatment for atherosclerosis assessed by multimodal imaging,” authored by M.E. Lobatto.

For more information: www.snm.org/cmiit

 

Related Content

Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
ScImage and Invia Partnership Announced
News | PACS | September 19, 2017
ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the American Society of...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Overlay Init